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Abstract  
Background: The relationship between body mass index (BMI) and dementia is complex and 
controversial. This study investigates the association of weight change during midlife and 
later dementia related mortality. 
Methods: Two BMI measurements (average of 9.0 years apart) were available for 43,721 
participants in the Norwegian Counties Study (NCS), with mean age 42 years at first BMI 
measurement and 51 at the final measurement. NCS was linked with the Cause of Death 
Registry until year 2015 (mean follow-up time 25.9 years). Cox regression with a conditional 
growth model was used. 
Results: Our study comprised 1,205 dementia related deaths. Weight loss was associated with 
increased dementia related mortality, irrespectively of baseline BMI and confounders; those 
with ≥10% loss had HR=1.52 (95 % confidence interval CI 1.09, 2.12) compared to those 
being stable (0-2.5% BMI gain), and those with 5-10% loss had HR=1.38 (95% CI 1.08, 
1.76). Gaining weigh was associated with reduced dementia related mortality. Associations 
with BMI change did not vary by baseline BMI. 
Conclusions: Weight loss during midlife was associated with increased dementia related 
mortality risk more than three decades later, while weight gain was associated with reduced 
risk. These associations held both for low and high baseline BMI. Weight loss was an 
independent risk factor for dementia related mortality and more strongly related with 
dementia related mortality than stable BMI (stable high or low). Overweight and obesity were 
associated with an increased risk for non-dementia related mortality, which was far more 
common than dementia related mortality.  
Key-words: Dementia, dementia related mortality, body weight, growth, weight loss, 
conditional growth.  
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Introduction 
The relationship between weight and dementia is complex (1). Some studies report 
overweight in midlife to be associated with increased dementia risk (2-4), others report a 
reduced dementia risk (5, 6) or a U-shaped association (1, 7, 8). The conflicting results may 
be attributable to the different ages at which weight was measured, which would imply that 
age matters (1, 7, 9). A better understanding of the association between body weight and 
dementia may be achieved by studying weight trajectories and patterns from midlife into old 
age (1). Studies with weight at multiple time points have generally reported weight loss (10-
18) or weight instability (19) to be associated with increased dementia risk. However, many 
of these studies are limited to weight trajectories in old age, and might be prone to reverse 
causality because dementia and preclinical dementia might cause weight loss (1, 20). 
Therefore, to study weight and weight change as risk factors for dementia outcomes it has 
been proposed that midlife weight and changes in midlife into old age may be more 
appropriate (21). The few studies covering weight in both midlife and old age have been 
criticized for not taking into account baseline weight, and therefore one cannot disentangle if 
it is weight change per se or baseline weight, or even an interaction between the two which 
matters most regarding dementia risk (1). 
 
Dementia related mortality has very high specificity and positive predictive values for clinical 
dementia diagnoses (22), and dementia related mortality might be a feasible proxy for clinical 
dementia diagnoses in epidemiological studies (23). In previous work we studied weight at 
single time points and found high body mass index (BMI) to be associated with decreased 
dementia mortality risk only when BMI was measured in old age, while low BMI was 
associated with increased risk regardless of age (8, 24). To expand upon these previous 
analyses, our aim was threefold; first to explore whether the effect of weight change in 
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midlife depends on baseline weight, and secondly to examine associations with changes in 
weight during midlife adjusted for baseline weight. Finally, we wanted to assess which is 
most important for dementia mortality: size through midlife or changes in size? 
Methods 
Study sample 
Repeated height and weight measurements were collected three times in the Norwegian 
Counties Study during 1974-88 (25). Study participants were born 1925-45 and were 35-49 
years at baseline, and 40-62 years at the final measurement (N=69,906), with an average of 
9.0 years between measurements. Our study sample comprised participants with two or three 
measurements of height and weight (N=46,774) (see flow chart in Figure 1). Participants with 
less than 5 years between baseline and follow-up measurement were removed to get a more 
homogenous population regarding time between measurements (n=1,916). Participants with 
missing measurements were removed (n=710). To make follow-up time more homogenous, 
participants with three measurements (n=29,155), the first and last were used. Finally, those 
with missing covariate values were removed (n=417). The final number of participants was 
43,721. The percentage of missing due to missing values for height, weight or covariates was 
2.5%.    
 
Body mass index 
Each respondent had two body mass index (BMI) values calculated as kg/m2. Baseline BMI 
was used as a continuous variable and as a categorical variable (<20 kg/m2, 20-24.9 kg/m2, 
25-29.9 kg/m2, ≥30 kg/m2). Percentage change in BMI was calculated as 100*(final BMI - 
baseline BMI)/(baseline BMI). Time between BMI measurements ranged 5-13 years. 
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Dementia related mortality 
Dementia related mortality was defined as a dementia diagnosis (ICD-9: 331.0, 294.1, 290.0-
290.4; ICD-10: F00-F03 and G30) recorded on the death certificate in The Norwegian Cause 
of Death Registry, either as the underlying cause of death or as a contributory cause. Study 
members were followed from final BMI assessment until death, emigration or until January 
1st 2015, whichever occurred first. 
 
Covariates 
Highest educational level in 1970 or 1980 was obtained from the National Education Data 
Base, and grouped: university degree and equivalents (high), advanced secondary 
qualifications (middle), and basic (public school/elementary school) (low). Based on self-
reports at baseline, participants were dichotomized according to diabetes status. Similarly, 
participants were dichotomized according to CVD status based on a history of cardiovascular 
disease (CVD), heart attack, angina, stroke, medical treatment of CVD, or symptoms of such 
diseases. Baseline smoking was dichotomized as daily smoker or not daily smoker. Baseline 
leisure time physical activity was grouped in four as reading or watching television mostly, 
light walking, moderate exercise, or intensive exercise. Based on a non-fasting blood sample 
at baseline, total cholesterol level was grouped in four categories: 5.20 mmol/l, 5.20–6.49 
mmol/l, 6.50–7.79 mmol/l and ≥7.80 mmol/l (26). The second measurements of resting 
diastolic and systolic blood pressures were used in the analyses. The respondents were 
categorized as hypertensive if they had systolic pressure ≥160 mmHg or diastolic pressure 
≥100 mmHg, and hypotensive if systolic pressure was ≤90 mmHg, or diastolic pressure was 
≤60 mmHg (27). 
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Statistics 
The association between BMI (and BMI change) with later dementia related mortality was 
analyzed using three sets of Cox regression models (with attained age as time variable). First, 
for validation purposes and being able to compare results to earlier studies, the association 
between baseline BMI (in categories) with dementia related mortality was analyzed, without 
taking into account later BMI change. Secondly, to explore whether the association of weight 
change in midlife with the outcome depends on baseline BMI, the association between 
percentage BMI change and dementia related mortality was analyzed separately for baseline 
BMI below and above 25 kg/m2 as well as combined.  
 
Thirdly, to examine the role of both baseline BMI and BMI changes through adulthood we 
fitted a conditional growth model that included both baseline BMI (𝐵𝑀𝐼0) and change in BMI 
(𝐵𝑀𝐼1 − 𝐵𝑀𝐼0) in the same Cox model (specified in appendix [1]). Baseline BMI and BMI 
change was treated as continuous variables in the “Cox growth model”, and interaction was 
investigated including baseline BMI multiplied by BMI change in the model. Additionally, to 
allow for deviation from linearity in the association between BMI (and BMI change) with 
dementia related mortality, the covariates of interest were modeled using linear splines with 
one knot, keeping the adjustment covariate continuous. So for example when BMI change 
was the main interest, change was modeled using two linear splines with a knot at 0, and 
baseline BMI was treated as a continuous variable. In the second model, linear splines were 
created for baseline BMI with a knot at 25 kg/m2 while holding BMI change as a continuous 
variable.  
 
To investigate the specificity of the associations, a second set of analyses, identical to those 
above were performed using non-dementia related mortality as outcome rather than dementia 
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related mortality. For sensitivity purposes additional analyses were run using dementia 
outcome restricted to underlying cause of death. Stata version 14.0 was used for analyses. 
Results 
Of the 43,721 study participants 18,312 died during follow-up and 1,205 were dementia 
related, either registered as the main cause or as the underlying cause of death (Table 1). 
Mean follow-up time was 25.9 years (minimum 0.22 years, maximum 35.0 years). Mean age 
at start of mortality follow-up (at second BMI measurement) was 51.0 years (minimum 39.9 
years, maximum 62.0 years), and at end of follow-up the mean age was 76.9 years (minimum 
41.5, maximum 90.0 years). The distribution of study participants across BMI categories at 
baseline was: 4% underweight (<20 kg/m2), 52% normal weight (20-24.9 kg/m2), 36% 
overweight (25-29.9 kg/m2) and 8% obese (≥30 kg/m2) (Table 2). At final BMI measurement 
the corresponding distribution was: 3%, 43%, 42% and 12%. Mean BMI at baseline was 25.1 
kg/m2 for men (SD 3.0) and 24.8 kg/m2 (SD 4.1) for women (Table 1). At follow-up, mean 
BMI was 25.8 kg/m2 (SD 3.2) in men and 25.7 kg/m2 (SD 4.4) in women. Mean change in 
BMI for men was 0.7 kg/m2 (SD 1.7) and 0.9 kg/m2 in women (SD 2.2). 
 
Not taking later weight change into account, low BMI (<20 kg/m2) at baseline was associated 
with increased risk of dementia related mortality compared with normal weight participants 
(Table 2). Adjusting for potential confounders made little difference to the result; HR=1.50 
(95% CI 1.13, 1.99) in a fully adjusted model. Neither baseline overweight nor obesity was 
associated with later dementia related mortality.  
 
There was no evidence that having a lower BMI at baseline and maintaining that lower BMI 
(over a period of 5-13 years) carried any significant extra risk of dementia related mortality, 
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likewise, starting with a higher BMI and maintaining that extra BMI was not associated with 
risk of dementia related mortality (Figure A1). For baseline BMI values below 25 kg/m2, a 
one unit higher BMI was associated with dementia related HR of 0.97, p=0.13, in a fully 
adjusted model, and for baseline BMI above 25 kg/m2 it was 0.99, p=0.87. HR results for 
baseline BMI below and above 25 kg/m2 did not significantly differ (test for difference in 
slopes above and below 25 kg/m2: p=0.31), so in Figure A1 baseline BMI was modeled 
continuously throughout the whole BMI range without splines. 
 
BMI loss of 10% or more was associated with a fifty two percent increased dementia related 
mortality risk compared with those with stable weight; HR=1.52, 95% confidence interval 
(CI) 1.09, 2.12 in a fully adjusted model (Table 3, Model 2). Also those with slightly less 
BMI loss (5-10%) had increased dementia related mortality risk; HR=1.38, 95% CI 1.08, 
1.76. Gaining weight was not associated with increased dementia related mortality risk. These 
results on BMI change and dementia related mortality risk (in Table 3) were similar in men 
and women (p-value testing for gender interaction: 0.92). Furthermore, HRs for BMI-change 
were similar between low (<25 kg/m2) and high (≥25 kg/m2) baseline BMI (p-value testing 
for interaction: 0.62).  
 
Losses in BMI, after covariate adjustment for baseline BMI, were associated with a higher 
risk of dementia related mortality, whereas BMI gains were associated with a lower risk 
(Figure A2); one unit BMI gain was associated with a significant dementia related HR of 0.95 
(p=0.001). In a model where BMI change was modeled as linear splines with one knot at 0, 
the slopes for BMI loss and BMI gain were identical; a one unit change was associated with 
HR=0.95. 
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To investigate what matters more regarding dementia related mortality risk, baseline BMI or 
BMI change, we formally tested differences in coefficients for baseline BMI and BMI change  
in the Cox growth model (appendix [1]) where the coefficients were modeled linearly without 
splines. The assumption about linearity seems feasible, as the slopes above and below the 
knot did not differ significantly, neither for baseline BMI nor for BMI change. The HR 
coefficient for baseline BMI was 0.99 (95% CI 0.97, 1.01), and for BMI change it was 0.95 
(95% CI 0.92, 0.98). Furthermore, the difference between these coefficients was significant 
(p=0.011), indicating that BMI change matters more than baseline BMI regarding the 
outcome. There was no evidence that dementia related mortality risk associated with BMI 
change differed in those with high and low baseline BMI (p=0.15 for the interaction term 
baseline BMI*BMI change). 
 
Analyses of non-dementia related mortality showed a significant u-shaped association with 
BMI at baseline, and a significant mirrored J-shape with BMI change (strongest association 
for those losing weight and a small increased risk for those gaining weight) (Appendix Table 
A1, and Figures A3 and A4).  
Discussion 
The novel finding in the present study is that weight change matters most regarding dementia 
related mortality risk, not baseline weight; losing weight was associated with increased risk, 
while putting on weight was associated with lower risk. This was true both for those with low 
and high baseline BMI. Having stable BMI through midlife (either being thin or having high 
BMI through midlife) was not associated with higher risk of dementia related mortality. These 
findings fit with the apparent paradox that obesity in old age seems to reduce dementia risk, 
while no such reduction in risk is observed for obesity in midlife (8, 9).  
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Our result regarding weight loss being associated with increased dementia related 
mortality risk fits with studies using clinical dementia as end point (10-18). Most previous 
studies investigate weight change in old age, typically above 65 years or older, where reverse 
causality might be a plausible explanation for the association between weight loss and 
dementia. For example weight loss in late life was associated with dementia in the Swedish 
Kungsholmen study (age 75 or older at baseline) (11), in a study of African-Americans (12) 
and in a study of Yoruba Nigerians (13) (age at baseline was 65 years or older in both 
studies). It has been found that preclinical dementia may cause weight loss already in the late 
50s, decades before the dementia diagnosis (20).  
We identified five studies which have, like us, linked weight change from midlife into 
old age to dementia outcomes, and in accordance with our findings, weight loss was 
associated with increased dementia risk in all these studies (14, 17-19, 28). First, in the 
Honolulu-Asia Aging Study, a study of Japanese American men, where age at inclusion was 
from late 40s and 60s and follow-up was until 90s for the oldest, it was reported that men that 
developed dementia lost significantly more weight during the years prior to the diagnosis, 
especially during the three year period prior to the diagnosis (14). Secondly, in the Baltimore 
Longitudinal Study of Aging, women losing weight between their 30s and 40s were at 
increased risk for Alzheimer's disease (AD) (18). Thirdly, in The Prospective Population 
Study of Women (PPSW), where Swedish women aged 38 to 60 years at baseline were 
followed over nearly four decades, it was reported that women developing dementia had a 
lesser increase in BMI compared to the increase seen in other women (28), and these 
trajectories were modified by the ApoE genotype after age 70 years; Women carrying the 
ApoE ɛ4 allele had a steeper BMI decline than non-carriers after age 70 years (29). The 
authors argued that it is plausible that the ApoE ɛ4 allele, which is tightly related to increased 
risk of Alzheimer’s disease, is associated with weight loss through reverse causality. 
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However, before age 70 years there was no indication of any modification by the ApoE 
genotype on the BMI trajectories and it is suggested that the association between BMI loss 
before 70 and dementia is driven by other aspects of the early phases of the underlying 
dementia disease (29). We were not able to investigate this in detail, but we question if the 
dementia prodromal could cause weight loss as early as ages between 35 and 62 years. Fourth, 
in the Finnish CAIDE study, both men and women were included, and weight loss between 
age 50 and 70 years was associated a 20% increased dementia in risk per unit BMI loss, 
which was robust to adjustment for a range of health related variables (17). Fifth, midlife 
weight variability (in either direction) was associated with increased dementia risk in the 
Israel Ischemic Heart Disease Project (19). Unfortunately weight change and interaction with 
baseline weight status was not addressed in these five studies. This is essential, as noted in a 
recent review study (1), because loss or gain in BMI might be differently associated with 
dementia outcomes in initially normal weight individuals compared with initially obese 
individuals.    
Why weight loss is related to dementia is poorly understood, and there is an ongoing 
discussion on this issue (1). One explanation is that the dementia disease itself can cause 
weight loss (reverse causality). This explanation is supported by results from the American 
HRS study, which reported that preclinical dementia was associated with weight loss in 
cognitive normal study participants (20). Another study reported no BMI differences 20 to 30 
years before dementia onset, but 10 to 20 years before onset of dementia women that 
developed dementia had lower BMI than controls, and this BMI gap widened the closer the 
year of dementia onset (16). Thus, weight loss seems to precede dementia diagnosis by 
several years, even decades. Some authors have suggested that this loss may be related to pre-
dementia apathy, loss of initiative, and reduced olfactory function (16). Our results are less 
prone to reverse causality as weight change is observed at fairly young ages (between ages 
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35-49 years at baseline and 40-62 years at BMI follow-up) and linked with dementia related 
mortality occurring up to three to four decades later. This makes it less likely that frailty and 
general poor health, which is found to be associated with weight loss, to be the full 
explanation for the weight loss dementia mortality link. 
As we have discussed previously (24, 30), using dementia related mortality as a proxy 
for clinical dementia diagnosis has its limitations (24, 30). Dementia cases still alive and those 
with dementia dying from other cause(s) than dementia will not be cases in our study. Hence, 
it is likely that cases in our study are those with the most severe dementia. The outcome 
variable in the present study included both those with dementia as accompanying and 
underlying cause of death, so we cannot rule out the possibility that there are other causes of 
death that are driving the observed associations with BMI. However, the results were similar 
when only underlying cause of death was used as dementia end point. Another possible source 
of bias in cohort studies is informative censoring. Most of the mortality in our study (93%) 
were non-dementia related, of which many occurred before reaching ages where dementia 
mortality is most prevalent (average age at death for non-dementia related mortality was 71 
years, while for dementia related mortality it was 79 years). Baseline obesity and overweight 
was associated with increased hazard of non-dementia related mortality, such as mortality 
from cardiovascular events, and it is possible that these heavy participants would be of high 
risk for dementia if they had survived, thereby attenuating the true associations. However, 
informative censoring does not seem likely for the associations with weight change, as weigh 
gain was only weakly associated with non-dementia related mortality. Because of this 
possible informative censoring bias we cannot rule out that our findings are restricted to those 
who survive other, much more common causes of mortality. The underreporting of dementia 
on the death certificates (31) will possibly blur any weak true associations between BMI and 
dementia related mortality. A study revealed that only 38-39% of residents of nursing homes 
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in Norway with dementia had dementia mentioned in their death certificate, thus quite low 
sensitivity (22). However, all of those having dementia mentioned in their death certificate 
had a dementia diagnosis – thus, high specificity and positive predictive values (100%) (22). 
Our recent findings, which showed that dementia related mortality risk for the various ApoE 
genotypes were in line with other reports using clinical dementia diagnoses as end point, 
suggest that dementia related mortality might be a feasible proxy for clinical dementia 
diagnoses in epidemiological studies (23). We performed a complete cases analysis using only 
individuals with non-missing values for all covariates in the fully adjusted regression model. 
Restricting the sample this way may introduce bias, but we believe this bias to be small as the 
complete cases sample comprised 97.5% of the total analytical sample. 
 
Interpretation 
Our results suggest that losing weight during midlife is associated with increased dementia 
related mortality risk up to four decades later, while gaining weight reduces risk. These 
associations hold both for low and high baseline BMI. Weight loss is an independent risk 
factor for dementia related mortality risk and more strongly related with the outcome than 
stable high or stable low BMI. The mechanisms linking weight loss in midlife and dementia 
in old age are poorly understood and are probably not only due to reverse causality. We will 
emphasize that our results do not support a recommendation that individuals should attempt to 
gain weight during mid-life or that obesity is not an important health risk factor; Both 
overweight and obesity were associated with at increased risk for non-dementia related 
mortality, which were far more common than dementia related mortality.  
 
Funding: The Norwegian Research Council. 
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Table and figure captions 
Table 1. Background table.  
 
Table 2. BMI at baseline and dementia related mortality and non-dementia related mortality,  
estimated with Cox regression.  
 
Table 3. BMI change and dementia related mortality hazard ratios (HR),  
estimated with Cox regression.  
 
Figure 1. Study population, flow-chart 
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Tables  
 
Table 1. Background table.  
 Dementia deaths/N  Mean 
baseline 
BMI (SD) 
Mean follow-up 
BMI (SD) 
 Baseline 
BMI<25 
 BMI Change* (%) 
       (%)  BMI  
loss 
Stable BMI BMI 
 gain 
Men 534/21725  25.1 (3.0) 25.8 (3.2)  51  17 33 50 
Women 671/21996  24.8 (4.1) 25.7 (4.4)  61  20 26 54 
Education           
  Low 673/22325  25.3 (3.8) 26.0 (4.1)  52  20 28 51 
  Middle 453/17931  24.8 (3.4) 25.6 (3.6)  58  17 30 53 
  High 79/3465  24.1 (3.0) 24.9 (3.3)  67  14 33 54 
Diabetic           
   No 1201/43460  25.0 (3.6) 25.8 (3.8)  56  18 30 52 
   Yes 4/261  26.0 (4.7) 26.4 (4.5)  49  29 26 44 
History of CVD           
   No 1125/41161  24.8 (3.4) 25.6 (3.8)  57  18 30 52 
  Yes 80/2560  27.0 (4.7) 27.7 (4.8)  36  23 27 50 
Daily smoking           
  No 723/24558  25.3 (3.7) 26.1 (3.9)  52  17 30 53 
  Yes 482/19163  24.5 (3.4) 25.3 (3.8)  60  20 29 50 
Physical activity, leisure time           
   Reads/TV mostly  3674/8534  25.4 (4.0) 26.3 (4.3)  51  21 27 52 
   Light walking 10,154/26426  24.9 (3.6) 25.7 (3.9)  57  18 29 53 
   Moderate exercise 3,156/8355  24.8 (3.0) 25.5 (3.3)  57  16 33 51 
   Intensive exercise 128/406  24.2 (2.2) 25.0 (2.5)  70  14 32 54 
20 
 
Tot. cholesterol mmol/l           
  <5.20 133/7557  24.1 (3.2) 25.0 (3.5)  67  15 30 55 
  5.20-6.49 515/18591  24.7 (3.5) 25.6 (3.8)  59  18 30 53 
  6.50-7.79 386/12795  25.5 (3.7) 26.2 (3.9)  49  20 29 51 
  ≥7.80 171/4778  25.9 (3.7) 26.6 (4.1)  43  22 29 52 
Hypertensive**           
  No 1045/38444  24.7 (3.4) 25.5 (3.7)  59  18 30 53 
  Yes 160/5277  26.8 (4.4) 27.4 (4.5)  36  23 30 46 
Hypotensive**           
  No 1193/43155  25.0 (3.6) 25.8 (3.8)  56  18 30 52 
  Yes 12/566  23.1 (2.9) 24.1 (3.2)  79  14 25 61 
* BMI loss defined as a BMI loss of 2.5% or more between baseline and follow-up; stable BMI is loosing or  
gaining less than 2.5%, and BMI gain is gaining more than 2.5%.  
** The respondents were categorized as hypertensive if they had systolic pressure ≥160 mmHg or diastolic pressure ≥100 mmHg, and 
hypotensive if systolic pressure was ≤90 mmHg, or diastolic pressure was ≤60 mmHg.  
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Table 2. BMI at baseline and dementia related mortality and non-dementia related mortality,  
estimated with Cox regression.  
 
 Dementia  
related mortality 
HR (95% CI) 
Non-dementia  
related mortality 
HR (95% CI) 
BMI baseline,  
adjusted by sex 
(number of dementia related 
deaths/number of individuals) 
  
    <20 kg/m2 (54/1822) 1.52 (1.15-2.01) 1.52 (1.41, 1.64) 
    20-24.9 kg/m2 (584/22604) 1.00  1.00  
    25-29.9 kg/m2 (463/15676) 1.08 (0.96, 1.22) 1.13 (1.10, 1.17) 
    ≥30 kg/m2 (104/3619) 1.11 (0.90, 1.37) 1.66 (1.58, 1.75) 
BMI baseline,  
fully adjusted* 
  
    <20 kg/m2 (54/1822) 1.50 (1.13-1.99) 1.38 (1.28, 1.49) 
    20-24.9 kg/m2 (584/22604) 1.00  1.00  
    25-29.9 kg/m2 (463/15676) 1.06 (0.94, 1.20) 1.13 (1.09, 1.16) 
    ≥30 kg/m2 (104/3619) 1.04 (0.84, 1.29) 1.51 (1.43, 1.59) 
* Adjusted by sex, total cholesterol, physical activity, history of heart disease/conditions, history of diabetes,  
education, smoking and blood pressure. 
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Table 3. BMI change and dementia related mortality hazard ratios (HR),  
estimated with Cox regression.  
 
BMI change  
(number of dementia related 
deaths/number of individuals) 
HR (95% CI)  
Model 1* 
HR (95% CI) 
Model 2* 
    Loss 10% or more (44/1296) 1.62 (1.16, 2.26) 1.52 (1.09, 2.12) 
    Loss 5-10% (104/3093) 1.42 (1.11, 1.82) 1.38 (1.08, 1.76) 
    Loss 2.5-5% (113/3612) 1.27 (1.01, 1.61) 1.26 (0.99, 1.59) 
    Loss 0-2.5% (194/6552) 1.13 (0.92, 1.38) 1.12 (0.91, 1.37) 
    Gain 0-2.5% (167/6393) 1 1 
    Gain 2.5-5% (170/6753) 0.95 (0.76, 1.17) 0.95 (0.77, 1.18) 
    Gain 5-10% (255/9268) 1.10 (0.91, 1.34) 1.11 (0.91, 1.35) 
    Gain 10-15% (102/3999) 1.07 (0.83, 1.37) 1.05 (0.82, 1.35) 
    Gain 15-20% (42/1629) 1.12 (0.79, 1.57) 1.09 (0.77, 1.53) 
    Gain 20% or more (14/1126) 0.58 (0.33, 1.00) 0.56 (0.32, 0.96) 
* Model 1: Adjusted by sex and time between BMI measurements;  
Model 2: + adjusted by total cholesterol, physical activity, history of heart disease/conditions,  
history of diabetes, education, smoking and blood pressure.  
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Appendix 
 
 
Conditional growth model to examine the role of both baseline BMI and changes in BMI 
through adulthood with dementia related mortality 
We fitted a conditional growth model that included both baseline BMI (𝐵𝑀𝐼0) and change in 
BMI (𝐵𝑀𝐼1 − 𝐵𝑀𝐼0) in the same Cox model as follows: 
 
ℎ(𝑡, 𝐵𝑀𝐼0, 𝐵𝑀𝐼1 ) = ℎ0(𝑡)exp (𝛶0𝐵𝑀𝐼0 + 𝛶1(𝐵𝑀𝐼1 − 𝐵𝑀𝐼0))    [1] 
 
Where ℎ(𝑡, 𝐵𝑀𝐼0, 𝐵𝑀𝐼1) is the dementia related mortality hazard rate at time t for a model 
with two covariates; the baseline BMI0 and the follow-up BMI1, and baseline hazard ℎ0(𝑡). 
Coefficient 𝛶0 captures the association of the outcome with being a BMI unit bigger at 
baseline conditional on later BMI change; it therefore assesses the association between being 
bigger or being smaller through follow-up with dementia mortality. The coefficient 𝛶1 
captures the association of the outcome with changes in BMI conditional on baseline BMI (1). 
 
1. Wills AK, Silverwood RJ, De Stavola BL. Comment on Tu et al. 2013. A critical 
evaluation of statistical approaches to examining the role of growth trajectories in the 
developmental origins of health and disease. International journal of epidemiology. 
2014;43:1662-1664. 
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Table A1. Change in BMI and non-dementia related mortality hazard ratios (HR),  
estimated in Cox regression with attained age as time scale.  
N=43,721; 17,107 non-dementia related deaths. 
 
BMI change  in %  
(number of individuals) 
HR (95% CI)  
Model 1* 
HR (95% CI) 
Model 2* 
Loss more than 10% (710/1296) 2.05 (1.89, 2.23) 1.71 (1.57, 1.86) 
Loss 5-10% (1468/3093) 1.47 (1.38, 1.57) 1.33 (1.25, 1.42) 
Loss 2.5-5% (1594/3612) 1.24 (1.16, 1.32) 1.19 (1.11, 1.26) 
Loss 0-2.5% (2691/6552) 1.08 (1.02, 1.14) 1.06 (1.00, 1.12) 
Gain 0-2.5% (2447/6393) 1 1 
Gain 2.5-5% (2469/6753) 0.95 (0.90, 1.00) 0.97 (0.92, 1.03) 
Gain 5-10% (3241/9268) 0.96 (0.91, 1.02) 0.97 (0.92, 1.03) 
Gain 10-15% (1462/3999) 1.10 (1.03, 1.18) 1.06 (0.99, 1.13) 
Gain 15-20% (591/1629) 1.17 (1.07, 1.29) 1.08 (0.99, 1.19) 
Gain 20% or more (434/1126) 1.35 (1.22, 1.50) 1.17 (1.06, 1.30) 
* Model 1: Adjusted by sex and time between BMI measurements;  
   Model 2: + adjusted for cardiovascular/life-style factors at baseline  
(total cholesterol, physical inactivity, history of heart disease/conditions,  
history of diabetes, education, smoking, blood pressure.  
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Figure A1. Baseline BMI and dementia mortality hazard ratios (HR) with 95% confidence 
intervals marked with dotted lines. Model is adjusted for later BMI change, sex and risk 
factors. Cox regression with attained age as time scale and baseline BMI modeled as a linear 
variable, adjusted for later BMI growth, sex, time between BMI measurements, and risk 
factors (total cholesterol, physical activity, history of heart disease/conditions, history of 
diabetes, education, smoking, blood pressure). N=43,721 and 1,205 dementia related deaths. 
Baseline BMI slope: HR=0.99, p=0.173. Model is described in [1] in appendix. 
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Figure A2. BMI change and dementia related mortality hazard ratios (HR) with 95% 
confidence intervals marked with dotted lines. Model is adjusted by baseline BMI, sex and 
risk factors.  Cox regression with attained age as time scale and BMI change modeled as a 
linear variable, adjusted for baseline BMI, sex, time between BMI measurements and risk 
factors (total cholesterol, physical activity, history of heart disease/conditions, history of 
diabetes, education, smoking, blood pressure). N=43,721, and 1,205 dementia related deaths. 
BMI change slope: HR=0.95, p=0.001. Model is described in [1] in appendix. 
 
 
 
  
28 
 
Figure A3. Baseline BMI and non-dementia related mortality hazard ratios (HR) with 95% 
confidence intervals marked with dotted lines. Model is adjusted for later BMI change, sex 
and risk factors. Cox regression with attained age as time scale and baseline BMI modeled as 
linear spline with one knot at 25, adjusted for BMI change, sex, time between BMI 
measurements and risk factors (total cholesterol, physical activity, history of heart 
disease/conditions, history of diabetes, education, smoking, blood pressure). N=43,721 and 
17,107 non-dementia related deaths. (Slopes test for difference from zero: spline 1 (BMI 
<25): HR=0.97, p<0.001, spline 2 (BMI >25): HR=1.05, p<0.001. Test for difference in 
baseline BMI slopes above and below 25: p<0.001). Model is described in [1] in appendix. 
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Figure A4. BMI change and non-dementia related mortality hazard ratios (HR) with 95% 
confidence intervals marked with dotted lines. Model is adjusted by baseline BMI, sex and 
risk factors. Cox regression with attained age as time scale and BMI change modeled as linear 
spline with one knot at 0, adjusted for baseline BMI, sex, time between BMI measurements 
and risk factors (total cholesterol, physical activity, history of heart disease/conditions, history 
of diabetes, education, smoking, blood pressure). N=43,721 and 17,107 non-dementia related 
deaths. (Slopes test for difference from zero: spline 1 (change below 0): HR=0.95,  p<0.001, 
spline 2 (change above 0): HR=1.004, p=0.47. Test for difference in slopes above and below 
0: p<0.001). Model is described in [1] in appendix. 
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Figure legends for figures in Appendix 
 
Table A1. Change in BMI and non-dementia related mortality hazard ratios (HR),  
estimated in Cox regression with attained age as time scale.  
N=43,721; 17,107 non-dementia related deaths. 
 
Figure A1. Baseline BMI and dementia mortality hazard ratios (HR) with 95% confidence 
intervals marked with dotted lines. Model is adjusted for later BMI change, sex and risk 
factors. Cox regression with attained age as time scale and baseline BMI modeled as a linear 
variable, adjusted for later BMI growth, sex, time between BMI measurements, and risk 
factors (total cholesterol, physical activity, history of heart disease/conditions, history of 
diabetes, education, smoking, blood pressure). N=43,721 and 1,205 dementia related deaths. 
Baseline BMI slope: HR=0.99, p=0.173. Model is described in [1] in appendix. 
 
Figure A2. BMI change and dementia related mortality hazard ratios (HR) with 95% 
confidence intervals marked with dotted lines. Model is adjusted by baseline BMI, sex and 
risk factors.  Cox regression with attained age as time scale and BMI change modeled as a 
linear variable, adjusted for baseline BMI, sex, time between BMI measurements and risk 
factors (total cholesterol, physical activity, history of heart disease/conditions, history of 
diabetes, education, smoking, blood pressure). N=43,721, and 1,205 dementia related deaths. 
BMI change slope: HR=0.95, p=0.001. Model is described in [1] in appendix. 
 
Figure A3. Baseline BMI and non-dementia related mortality hazard ratios (HR) with 95% 
confidence intervals marked with dotted lines. Model is adjusted for later BMI change, sex 
and risk factors. Cox regression with attained age as time scale and baseline BMI modeled as 
linear spline with one knot at 25, adjusted for BMI change, sex, time between BMI 
measurements and risk factors (total cholesterol, physical activity, history of heart 
disease/conditions, history of diabetes, education, smoking, blood pressure). N=43,721 and 
17,107 non-dementia related deaths. (Slopes test for difference from zero: spline 1 (BMI 
<25): HR=0.97, p<0.001, spline 2 (BMI >25): HR=1.05, p<0.001. Test for difference in 
baseline BMI slopes above and below 25: p<0.001). Model is described in [1] in appendix. 
 
Figure A4. BMI change and non-dementia related mortality hazard ratios (HR) with 95% 
confidence intervals marked with dotted lines. Model is adjusted by baseline BMI, sex and 
risk factors. Cox regression with attained age as time scale and BMI change modeled as linear 
spline with one knot at 0, adjusted for baseline BMI, sex, time between BMI measurements 
and risk factors (total cholesterol, physical activity, history of heart disease/conditions, history 
of diabetes, education, smoking, blood pressure). N=43,721 and 17,107 non-dementia related 
deaths. (Slopes test for difference from zero: spline 1 (change below 0): HR=0.95,  p<0.001, 
spline 2 (change above 0): HR=1.004, p=0.47. Test for difference in slopes above and below 
0: p<0.001). Model is described in [1] in appendix. 
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